Pharmacology · single question

Mechanism of action of Humira (adalimumab):

  1. TNF-alpha inhibitor (monoclonal antibody against TNF-α)
  2. Interleukin-2 receptor blocker
  3. RANKL inhibitor
  4. Calcineurin inhibitor
Show answer and explanation

Correct answer: A. TNF-alpha inhibitor (monoclonal antibody against TNF-α)

  • A. Correct. Adalimumab is a monoclonal antibody that binds and inhibits TNF-α, reducing inflammation in conditions like rheumatoid arthritis, Crohn's disease, and psoriasis.
  • B. IL-2 receptor blockers (e.g., basiliximab) are different biologics, used mainly in transplant rejection prophylaxis.
  • C. RANKL inhibition describes denosumab's mechanism, not adalimumab's.
  • D. Calcineurin inhibitors (e.g., cyclosporine, tacrolimus) work through a completely different immunosuppressive pathway.

Practice Pharmacology questions Pharmacology study notes

More Pharmacology practice questions